Resveratrol reverts Streptozotocin-induced diabetic nephropathy

被引：12
|
作者：
Zhu, Huiping [1 ,2 ]
Zhong, Sen [1 ,2 ]
Yan, Haihong [1 ,2 ]
Wang, Kangyao [1 ,2 ]
Chen, Lingwei [1 ,2 ]
Zhou, Min [1 ,2 ]
Li, Yunsheng [1 ,2 ]
机构：
[1] Wenzhou Med Univ, Peoples Hosp Wenling 1, Dept Nephrol, 333 Chuanan Rd, Wenling 317500, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Wenling Hosp, 333 Chuanan Rd, Wenling 317500, Zhejiang, Peoples R China
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2020年 / 25卷
关键词：
Resveratrol; Renal dysfunction; Diabetic nephropathy; mTOR/ULK1; pathway; Autophagy; RENAL LIPID-METABOLISM; PODOCYTE FUNCTION; AUTOPHAGY; MICE; ACCUMULATION; PROGRESSION; PROTECTS; FIBROSIS; TARGET; MTOR;
D O I：
10.2741/4829
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Diabetes causes diabetic nephropathy (DN) which is associated with increased morbidity and mortality in diabetic patients. We tested whether Resveratrol (Res) reverses the systemic effect of Streptozotocin (STZ) induced diabetes and DN. Res treatment opposed the effect of STZ on kidney weight, 24 h urinary albumin excretion, blood urea nitrogen (BUN) and serum creatinine (Scr). Res also decreased DN induced mTOR/ULK1-mediated autophagy and apoptosis and significantly reduced STZ mediated lipid deposition in nephrons, likely by decreasing the levels of lipogenic related proteins (SREBP-1c, ACS) and increased lipidolysis related proteins (PPAR alpha, CPT-1). Together, these findings show the potential of Res in prevention of diabetic nephropathy.
引用
收藏
页码：699 / 709
页数：11
相关论文
共 50 条
  • [21] Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats
    Lixia Tang
    Ke Li
    Yan Zhang
    Huifang Li
    Ankang Li
    Yuancheng Xu
    Bing Wei
    Scientific Reports, 10
  • [22] Effect of levosimendan, an inodilator, on streptozotocin-induced diabetic nephropathy in rats
    Abdelrahman, Aly M.
    Al Salam, Suhail
    Al Suleimani, Yousuf
    Ashique, Mohamed
    Manoj, Priyadarsini
    Ali, Badreldin H.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 873
  • [23] Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice
    Katoh, M
    Ohmachi, Y
    Kurosawa, Y
    Yoneda, H
    Tanaka, N
    Narita, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 398 (03) : 381 - 387
  • [24] Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats
    Huang, Hong
    Jiang, Ying
    Mao, Genxiang
    Yuan, Fang
    Zheng, Hexin
    Ruan, Yuan
    Wu, Tianfeng
    JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE, 2017, 97 (04) : 1359 - 1366
  • [25] Effect of Levosimendan, an Inodilator, on Streptozotocin-Induced Diabetic Nephropathy in Rats
    Ali, Badreldin
    Al-Salam, Suhail
    Al Sulemani, Yousuf
    Abdelrahman, Aly
    FASEB JOURNAL, 2020, 34
  • [26] COMBINED EFFECTS OF LEFLUNOMIDE AND BENAZEPRIL IN STREPTOZOTOCIN-INDUCED DIABETIC NEPHROPATHY
    Hua, Jin
    Guo, Piao Shang
    Zhe, Jin Ji
    Lan, Zheng Hai
    Can, Li
    NEPHROLOGY, 2014, 19 : 90 - 90
  • [27] Renoprotective Effect of Berberine on Streptozotocin-induced Diabetic Nephropathy Rats
    Wu, Zhufeng
    Xie, Zhanxiong
    Liu, Jianghong
    Wu, Qunhua
    Wang, Xiaokang
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2017, 13 (03) : 247 - 256
  • [28] Pterostilbene Ameliorates Nephropathy Injury in Streptozotocin-Induced Diabetic Rats
    Zhang, Ying
    Ren, Shaoyu
    Ji, Ying
    Liang, Yafeng
    PHARMACOLOGY, 2019, 104 (1-2) : 71 - 80
  • [29] The ameliorative potential of Hyphaene thebaica on streptozotocin-induced diabetic nephropathy
    AbdEl-moniem, M.
    Mustafa, H. N.
    Megahed, H. A.
    Agaibyi, M. H.
    Hegazy, G. A.
    El-Dabaa, M. A.
    FOLIA MORPHOLOGICA, 2015, 74 (04) : 447 - 457
  • [30] Streptozotocin-induced diabetic nephropathy in rats: The role of inflammatory cytokines
    Mensah-Brown, EPK
    Obineche, EN
    Galadari, S
    Chandranath, E
    Shahin, A
    Ahmed, I
    Patel, SM
    Adem, A
    CYTOKINE, 2005, 31 (03) : 180 - 190
12345